-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BOaWYIAe/oNXYjyGxh5crAdsNzSQLVpSg3qwEHvPAQroFL5Rw6th7rjxlQZ5KN9Q pr5MIv6bTnvPjPOoyhf73Q== 0001171843-10-001122.txt : 20100617 0001171843-10-001122.hdr.sgml : 20100617 20100617160209 ACCESSION NUMBER: 0001171843-10-001122 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100611 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20100617 DATE AS OF CHANGE: 20100617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 10903291 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 8-K 1 f8k_061410.htm FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_______________________________
 
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): June 11, 2010
 
Immunomedics, Inc.
(Exact Name of Registrant as Specified in Charter)
 
 
Delaware 000-12104 61-1009366
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
 
 
300 American Road, Morris Plains, New Jersey 07950
(Address of Principal Executive Offices)
(Zip Code)
 
(973) 605-8200
(Registrant's telephone number,
including area code)

Not applicable
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
 
 
 
 
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
As previously disclosed on May 3, 2010, Dr. Edward T. Wolynic had informed Immunomedics, Inc. (the “Company”) of his intention not to stand for re-election at the Company’s next Annual Meeting of Stockholders, scheduled to be held in December 2010.  However, due to an increase in demand for his consulting and advisory services, on June 11, 2010, Dr. Wolynic informed the Company that his resignation will now be effective as of June 14, 2010.  Dr. Wolynic has also informed the Company that his resignation is not due to any disagreement between Dr. Wolynic and the Company on any matter relating to the Company’s operations, policies or practices.
 
 
 
 
 

 
 
 
 
SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
IMMUNOMEDICS, INC.
 
 
 
  By:      /s/ Cynthia L. Sullivan
 
Name:  Cynthia L. Sullivan
Title:    President and Chief Executive Officer


 
Date:  June 17, 2010
 -----END PRIVACY-ENHANCED MESSAGE-----